The Myomectomy Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
In recent years, the myomectomy market has seen significant growth. The market size is projected to increase from $1.5 billion in 2024 to $1.62 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%.
By 2029, the myomectomy market is forecasted to reach a size of $2.23 billion, growing at a compound annual growth rate (CAGR) of 8.2%.
Download Your Free Sample of the 2025 Myomectomy Market Report and Uncover Key Trends Now!The key drivers in the myomectomy market are:
• Increasing number of women seeking fertility-preserving treatments
• Expanding access to specialized gynecological care
• Growing prevalence of uterine disorders
• Rising healthcare expenditure on advanced surgical interventions
The myomectomy market covered in this report is segmented –
1) By Type: Abdominal Myomectomy, Hysteroscopic Myomectomy, Laparoscopic Myomectomy
2) By Product: Laparoscopic Power Morcellators, Harmonic Scalpel, Laparoscopic Sealer, Other Products
3) By End-User: Hospitals And Clinics, Surgical Centers, Medical Device Companies, Other End-Users
Subsegments:
1) By Abdominal Myomectomy: Open Abdominal Myomectomy (Laparotomy), Mini-Laparotomy Myomectomy
2) By Hysteroscopic Myomectomy: Resectoscopic Myomectomy, Non-Resectoscopic Techniques
3) By Laparoscopic Myomectomy: Conventional Laparoscopic Myomectomy, Robotic-Assisted Laparoscopic Myomectomy
The key trends in the myomectomy market are:
• Minimally invasive and robotic-assisted surgical techniques are key emerging trends.
• The integration of artificial intelligence into surgical planning is shaping the future of the market.
• The development of personalized treatment plans based on genetic profiling is a significant emerging trend.
• Advancements in non-invasive diagnostic tools and a focus on patient-centered care and postoperative recovery improvements are reshaping the market.
Major players in the myomectomy market are:
• AbbVie Inc.
• Medtronic plc
• Stryker Corporation
• Mayo Clinic
• Boston Scientific Corporation
• Johnson Hopkins Medicines
• B. Braun Melsungen AG
• Olympus Corporation
• Intuitive Surgical Inc.
• Smith & Nephew plc
• Hologic Inc.
• Columbia University Irving Medical Center
• CooperSurgical Inc.
• Teleflex Incorporated
• Karl Storz SE & Co. KG
• CONMED Corporation
• Richard Wolf GmbH
• Park Hospital
• Phoenix Medical Devices
• ERBE Elektromedizin GmbH
• Advin Health Care
• Sterling Surgicals
• LiNA Medical ApS
North America was the largest region in the myomectomy market in 2024